Breast cancer firm makes breakthrough
by Peter Kneller - Wednesday, 23rd April 2008 -
University of Bristol spin-out Micrima secures significant investment to push forward its imaging technology.
YFM Group and Swarraton Partners have led a £2m (€2.5m) investment in Micrima, which is developing radio wave technology to improve detection of breast cancer.
Existing investor the National Endowment of Science, Technology and the Arts also participated in the funding.
University of Bristol spin-out Micrima, led by executive chairman Roy Johnson (pictured), is developing a breast imaging system that captures high resolution, 3D images through the use of harmless radio waves.
Its MARIA (multistatic array processing for radiowave image acquisition) system can provide better images for the dense tissue associated with the under 50s age group, and is also relatively inexpensive and completely safe for the patient.
The product’s low cost and compact size allow for its practical use in numerous alternative locations such as GP surgeries, diagnostic centres and mobile screening units.
Funding will go toward ongoing technical development and further clinical trials at the Frenchay Hospital’s Breast Clinic in Bristol.
Related tags: venture capital, micrima, breast imaging, breast cancer, roy johnson, raising finance, investment, university of bristol,
BUSINESS NEWS >>
By Real Business - May 15, 2008 4:09pm GMT
By Kate Pritchard - May 14, 2008 3:52pm GMT
By Melissa Hancock - May 14, 2008 2:25pm GMT
By Stuart Rock - May 14, 2008 11:35am GMT
By Stuart Rock - May 14, 2008 9:43am GMT
BUSINESS COMMENT >>
By Matthew Rock - May 14, 2008 10:40pm GMT
By Rebecca Burn-Callander - May 14, 2008 5:45pm GMT
By Catherine Woods - May 12, 2008 5:09pm GMT
By Matthew Rock - May 09, 2008 5:09pm GMT
By Matthew Rock - May 07, 2008 10:07pm GMT







